Pyridostigmine Bromide
- Product NDC
- 0115-2134
- 11-digit product format
- 001152134
- Labeler code
- 0115
- Product ID
- 0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PYRIDOSTIGMINE BROMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Application
- ANDA040502
- Marketing category
- ANDA
- Marketing start
- 2022-08-08
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pyridostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 30 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903841 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0115-2134-01 | Pyridostigmine Bromide | 21 in 1 BOTTLE | TABLET | 21 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0115-2134 | PYRIDOSTIGMINE BROMIDE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 2 | Current NDC, Legacy NDC, 1 package rows | 20240101_91ca7bcf-d2cc-4cb3-bfbe-c294fd707524.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0115-2134-01 | 00115213401 | 21 TABLET in 1 BOTTLE (0115-2134-01) | 21 tablet | 2022-08-08 | 0000-00-00 | No | No | Current |